Tazarotene 0.1% Gel in the Treatment of Fingernail Psoriasis: A Double-Blind, Randomized, Vehicle-Controlled Study

Article Type
Article
Changed
Thu, 12/15/2022 - 15:17
Display Headline
Tazarotene 0.1% Gel in the Treatment of Fingernail Psoriasis: A Double-Blind, Randomized, Vehicle-Controlled Study
Author(s)
Scher RK
Stiller M
Zhu YI

Article PDF
068050355.pdf
Author and Disclosure Information

Scher RK, Stiller M, Zhu YI

Issue
Cutis - 68(5)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Hair & Nails
Psoriasis
Page Number
355-358
Sections
Original Research
Clinical Topics & News
Author(s)
Scher RK
Stiller M
Zhu YI
Author(s)
Scher RK
Stiller M
Zhu YI
Author and Disclosure Information

Scher RK, Stiller M, Zhu YI

Author and Disclosure Information

Scher RK, Stiller M, Zhu YI

Article PDF
068050355.pdf
Article PDF
068050355.pdf

Issue
Cutis - 68(5)
Issue
Cutis - 68(5)
Page Number
355-358
Page Number
355-358
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Hair & Nails
Psoriasis
Article Type
Article
Display Headline
Tazarotene 0.1% Gel in the Treatment of Fingernail Psoriasis: A Double-Blind, Randomized, Vehicle-Controlled Study
Display Headline
Tazarotene 0.1% Gel in the Treatment of Fingernail Psoriasis: A Double-Blind, Randomized, Vehicle-Controlled Study
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Stiller M